Novarna

CircNova

This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.

Inceptive Nucleics

This company develops artificial intelligence models to design novel RNA-based medicines and biotechnologies for pharmaceutical and biotechnology partners.

Kerna

This company develops an artificial intelligence platform to design and deliver messenger ribonucleic acid medicines for patients with previously untreatable conditions.

Serna Bio

This company develops an AI-native platform to discover small molecule drugs targeting RNA for pharmaceutical partners treating respiratory and other complex diseases.

Noara Therapeutics

This company engineers stable and immunosilent ribonucleic acid therapies using machine intelligence to treat patients with chronic and complex diseases.

Revona Bio

The company develops an RNA-targeted drug discovery platform to identify small-molecule compounds for pharmaceutical partners and biotechnology firms.

Veritas In Silico

The company develops an AI-driven drug discovery platform for identifying mRNA-targeted medicines for pharmaceutical industry partners.

Creyon Bio

This company develops AI-designed oligonucleotide-based medicines and RNA-targeted therapies for pharmaceutical partners and patients with neuromuscular and immunological diseases.